Stopped early
Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer
NCT01644136 · Ohio State University Comprehensive Cancer Center · Updated 28 June 2018
- What is being tested
- robot-assisted laparoscopic surgery; regional lymph node dissection; microsphere-mediated lymphocele prevention
- For
- Lymphocele; Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 99 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 14 July 2011, ends 6 May 2014. Registered 18 July 2012.
- Results
- None posted yet.
In the researchers' words
This study is being performed to investigate if the application of Arista absorbable hemostat (AH)®, a product approved to stop surgical bleeding, can prevent lymphoceles. Lymphoceles are collections of lymphatic fluid which can occur after a lymph node dissection for cancer. These fluid collections can become symptomatic in some patients. Arista would be applied to one side of the pelvis after a pelvic lymph node dissection, to see if this decreases the number of postoperative lymph fluid collections seen on a computed tomography (CT) scan after surgery
Sites
- The Ohio State University Medical CenterColumbus, Ohio, United States